Sign in

CIK 0001640266

  • Accelerated filer
  • Smaller reporting company

Voyager Therapeutics, Inc.

Sign in to watch
Ticker
VYGR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 857-259-5340
Business address
75 HAYDEN AVENUE, LEXINGTON, MA, 02421
  1. 4 Planned sale President and CEO sold 11,732 shares at $3.41 ($40,006)
  2. 4 Open-market sale COO & CBO sold 4,569 shares at $3.85 ($17,591)
  3. 4 Open-market sale President and CEO sold 12,192 shares at $3.78 ($46,086)
  4. 4 Open-market sale Chief Scientific Officer sold 3,525 shares at $3.85 ($13,571)
  5. 4 Grant or award Chief Medical Officer acquired 45,000 shares (grant or award)
  6. 4 Grant or award Chief Scientific Officer acquired 33,000 shares (grant or award)
  7. 4 Grant or award COO & CBO acquired 45,000 shares (grant or award)
  8. 4 Grant or award President and CEO acquired 86,250 shares (grant or award)
  9. 4 Grant or award Chief Financial Officer acquired 32,250 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Planned sale Chief Financial Officer sold 7,666 shares at $4.78 ($36,643)
  13. 4 Open-market sale Chief Medical Officer sold 19,000 shares at $3.73 ($70,870)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 16 · 312 filings